[1]万凌燕,朱 健,范永荣.临床药师参与肾衰竭患者抗感染药个体化给药的药学监护效果[J].医学信息,2024,37(14):146-149.[doi:10.3969/j.issn.1006-1959.2024.14.030]
　WAN Ling-yan,ZHU Jian,FAN Yong-rong.Pharmaceutical Care Effect of Clinical Pharmacists Participating in Individualized Administration of Anti-infective Drugs in Patients with Renal Failure[J].Journal of Medical Information,2024,37(14):146-149.[doi:10.3969/j.issn.1006-1959.2024.14.030]
点击复制

临床药师参与肾衰竭患者抗感染药个体化给药的药学监护效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年14期
页码:
146-149
栏目:
论著
出版日期:
2024-07-15

文章信息/Info

Title:
Pharmaceutical Care Effect of Clinical Pharmacists Participating in Individualized Administration of Anti-infective Drugs in Patients with Renal Failure
文章编号:
1006-1959（2024）14-0146-04
作者:
万凌燕; 朱 健; 范永荣
（铅山县中医院药剂科，江西 铅山 334500）
Author(s):
WAN Ling-yan; ZHU Jian; FAN Yong-rong
(Department of Pharmacy,Yanshan County Hospital of Traditional Chinese Medicine,Yanshan 334500,Jiangxi,China)
关键词:
临床药师; 肾衰竭; 抗感染药; 个体化给药; 药学监护
Keywords:
Clinical pharmacists; Renal failure; Anti-infective drugs; Individualized administration; Pharmaceutical care
分类号:
R97
DOI:
10.3969/j.issn.1006-1959.2024.14.030
文献标志码:
A
摘要:
目的 研究临床药师参与肾衰竭患者抗感染药个体化给药的药学监护效果。方法 选取2022年1月-2023年1月我院接诊的80例肾衰竭患者为研究对象，运用随机数字表法分为观察组（n=40）和对照组（n=40）。对照组由临床医生开具医嘱，观察组由临床医生开具医嘱，临床药师对患者实施药学服务，比较两组治疗效果、血压达标率、血红蛋白达标率、血清钙达标率、炎症因子水平、用药依从性及不良反应发生率。结果 观察组治疗总有效率为92.50%，高于对照组的82.50%（P＜0.05）；观察组血压达标率、血红蛋白达标率及血清钙达标率均高于对照组（P＜0.05）；两组干预后C反应蛋白（CRP）、白细胞介素（IL-6）、肿瘤坏死因子（TNF-α）水平均低于干预前，且观察组低于对照组（P＜0.05）；观察组用药依从性良好率为97.50%，高于对照组的85.00%（P＜0.05）；观察组不良反应发生率为5.00%，低于对照组的15.00%（P＜0.05）。结论 临床药师参与肾衰竭患者抗感染药个体化给药的药学监护可提高给药合理性，降低不良反应发生率，提高治疗效果，提升血压、血红蛋白及血清钙达标率，并且可降低炎症因子水平。
Abstract:
Objective To study the pharmaceutical care effect of clinical pharmacists participating in individualized administration of anti-infective drugs in patients with renal failure.Methods A total of 80 patients with renal failure who were admitted to our hospital from January 2022 to January 2023 were selected as the research objects. They were divided into observation group (n=40) and control group (n=40) by random number table method. The control group was given medical advice by clinicians, and the observation group was given medical advice by clinicians. Clinical pharmacists provided pharmaceutical services to patients. The treatment effect, blood pressure compliance rate, hemoglobin compliance rate, serum calcium compliance rate, inflammatory factor level, medication compliance and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 92.50%, which was higher than 82.50% in the control group (P<0.05). The blood pressure compliance rate, hemoglobin compliance rate and serum calcium compliance rate in the observation group were higher than those in the control group (P<0.05). After intervention, the levels of C-reactive protein (CRP), interleukin (IL-6) and tumor necrosis factor (TNF-α) in the two groups were lower than those before intervention, and those in the observation group were lower than those in the control group (P<0.05). The good rate of medication compliance in the observation group was 97.50%, which was higher than 85.00% in the control group (P<0.05). The incidence of adverse reactions in the observation group was 5.00%, which was lower than 15.00% in the control group (P<0.05).Conclusion Clinical pharmacists participating in individualized administration of anti-infective drugs in patients with renal failure can promote the rationality of administration, reduce the incidence of adverse reactions, improve the therapeutic effect, improve the compliance rate of blood pressure, hemoglobin and serum calcium, and reduce the level of inflammatory factors.

参考文献/References:

[1]Tragiannidis A,Gkampeta A,Vousvouki M,et al.Antifungal agents and the kidney: phar macokinetics,clinical nephrotoxicity,and interactions[J].Expert Opin Drug Saf,2021,20(9):1061-1074.[2]刘丹丹.医疗机构充分发挥临床药师作用的研究[D].郑州:河南中医药大学,2018.[3]Chen R,Xu L,Zhang X,et al.Protective effect and mechanism of She nkang injection on adenine-induced chronic renal failure in rats[J].Acta Cir Bras,2022,37:e370304.[3]Rayego-Mateos S,Marquez-Expósito L,Rodrigues-Diez R,et al.Molecular Mechanisms of Kidney Injury and Repair[J].Int J Mol Sci,2022,23(3):1542.[4]袁海玲,徐丽婷.1例卡马西平致急性肾衰竭及血小板减少患者的药学服务[J].中国临床药学杂志,2020,29(4):308-311.[5]胡源晖,裴毓瑶,于锋,等.临床药学专业药学监护课程培养体系探析[J].药学教育,2023,39(6):59-65.[6]郝鹏飞,钟书婷,张超云,等.大黄附子汤治疗慢性肾衰竭的网络药理学研究及初证[J].中国医院药学杂志,2020,40(5):515-521.[7]王旭,张静,努尔比亚·阿布都热西提,等.前列地尔联合贝前列素钠辅助血液透析对老年慢性肾衰竭患者的残余肾功能、炎性因子、血脂、血液黏度及营养状况的影响[J].广西医学,2020,42(20):2665-2669.[8]张旺,韩璐.临床药师对感染性心内膜炎瓣膜置换术后合并急性肾衰竭患者的药学监护[J].中南药学,2019,17(9):1539-1543.[9]Chaudhuri A,Ghanim H,Arora P.Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology,mechanisms,and evidence from recent trials[J].Diabetes Obes Metab,2022,24(3):365-376.[10]龚婧如,严天浩,杨涛,等.卒中合并高血压门诊患者药学服务模式的建立与效果评价[J].临床药物治疗杂志,2022,20(10):49-53. [11]田丹,李静,李晓烨,等.沙库巴曲缬沙坦钠处方点评及用药合理性分析[J].中国医院药学杂志,2022,42(17):1837-1841.[12]向英,刘俊秀,廖静,等.住院患者服药依从性管理及影响因素分析[J].医学信息,2016,29(11):61-62.[13]谢玲,喻业安.临床药师参与1例血液透析伴尿路感染患者万古霉素个体化用药方案制定[J].药物流行病学杂志,2019,28(9):610-612.[14]葛丽烨,徐红冰,高岸,等.1例头孢他啶阿维巴坦钠治疗急性肾衰竭伴重症感染患者的分析和药学监护[J].中南药学,2022,20(3):698-702.[15]Aguilar-Gallardo JS,Correa A,Contreras JP.Cardio-renal benefits of sodium glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence[J].Eur Heart J Cardiovasc Pharmacother,2022,8(3):311-321.[16]]陈永妍,王高彪,于丽.临床药师参与洋葱伯克霍尔德菌肺炎个体化用药治疗的临床实践[J].上海医药,2023,44(3):71-74.[17]杨宝春,孙欣,杨欣,等.临床药师参与1例尿路感染伴药物热患者药学实践[J].中国药物警戒,2022,19(5):572-573,578.[18]史银春,闫璞,陈宗俊,等.基于医案研究的国医大师吕仁和治疗肾病综合征经验浅析[J].辽宁中医杂志,2021,48(11):42-45.[19]丁泉友,甘文莉,关国琼.药学服务对肾衰血液透析患者临床疗效及用药依从性的影响[J].基层医学论坛,2020,24(7):1016-1017.[20]柳海环,柳海琛,吴晨帆,等.处方点评制度对门急诊抗菌药物处方比例的影响[J].中国临床药学杂志,2018,27(2):125-129.

相似文献/References:

[1]吴国才.临床药师参与1例社区获得性MRSA肺炎治疗的病例报告[J].医学信息,2018,31(21):190.[doi:10.3969/j.issn.1006-1959.2018.06.058]
[2]徐 冬.临床药学服务平台的构建与应用[J].医学信息,2018,31(24):22.[doi:10.3969/j.issn.1006-1959.2018.24.006]
　XU Dong.Construction and Application of Clinical Pharmacy Service Platform[J].Journal of Medical Information,2018,31(14):22.[doi:10.3969/j.issn.1006-1959.2018.24.006]
[3]邵永康.维持性血液透析患者并发症的发病机制分析[J].医学信息,2019,32(17):35.[doi:10.3969/j.issn.1006-1959.2019.17.012]
　SHAO Yong-kang.Pathogenesis Analysis of Complications in Maintenance Hemodialysis Patients[J].Journal of Medical Information,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.17.012]
[4]罗宏丽,张伦会,王国俊,等.我院临床药师岗位培训招生现状及启发[J].医学信息,2019,32(18):107.[doi:10.3969/j.issn.1006-1959.2019.18.035]
　LUO Hong-li,ZHANG Lun-hui,WANG Guo-jun,et al.The Status Quo and Enlightenment of Clinical Pharmacist Post Training Enrollment in Our Hospital[J].Journal of Medical Information,2019,32(14):107.[doi:10.3969/j.issn.1006-1959.2019.18.035]
[5]董明伟.癌性疼痛规范化诊疗中临床药师的药学监护作用[J].医学信息,2020,33(11):151.[doi:10.3969/j.issn.1006-1959.2020.11.049]
　DONG Ming-wei.The Pharmacological Monitoring Function of Clinical Pharmacists in the Standardized Diagnosis and Treatment of Cancer Pain[J].Journal of Medical Information,2020,33(14):151.[doi:10.3969/j.issn.1006-1959.2020.11.049]
[6]程贵胜,彭彩霞,许 莺,等.基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的研究[J].医学信息,2024,37(07):120.[doi:10.3969/j.issn.1006-1959.2024.07.023]
　CHENG Gui-sheng,PENG Cai-xia,XU Ying,et al.Study on Clinical Observation and Pharmaceutical Care of Patients with Chronic Heart Failure Based on the Platform of Clinical Pharmacists and Medical Alliance[J].Journal of Medical Information,2024,37(14):120.[doi:10.3969/j.issn.1006-1959.2024.07.023]

更新日期/Last Update: 1900-01-01